“…In this context, the aim of this paper was to evaluate the antimicrobial features of new O-aryl-carbamoyl-oxymino-fluorene derivatives, previously reported for their inhibitory activity against Gram-positive (e.g., Bacillus anthracis , S. aureus , including methicillin resistant strains) and Gram-negative ( Escherichia coli , Proteus mirabilis , K. pneumoniae , P. aeruginosa , Burkholderiathailandensis and Francisella tularensis ) bacterial strains, mycobacteria, yeasts and molds [ 14 , 15 , 16 , 17 ]. The antioxidant activity of these compounds has been also evaluated, as it could represent an advantage for novel antimicrobial leads by decreasing the intensity and duration of the inflammatory response often accompanying the infectious process, thus avoiding their deleterious effects on the host tissues [ 18 ]. It is well known that oxidative stress represents an imbalance between the generation of free radicals and a decrease in the concentration of endogenous antioxidants (such as glutathione, vitamin C, vitamin E and a series of enzymes—catalase, superoxide dismutase and peroxidases) [ 19 ].…”